InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: dr_lowenstein post# 43557

Saturday, 03/31/2018 7:50:57 PM

Saturday, March 31, 2018 7:50:57 PM

Post# of 48316
Charles Duncan for Piper Jaffray seems reputable to me even if his Oncosec price target is below the rest at $4. That is still more than double the current stock price. http://www.piperjaffray.com/2col.aspx?id=7&analystid=1275&title=Analyst%20Information%20for%20Charles%20Duncan,%20PhD